Follow-up MRI scans for suspicious prostate lesions
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether repeat MRI scans can help monitor suspicious prostate areas and avoid unnecessary biopsies. It aims to improve detection of significant prostate cancer while reducing invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- Your PSA blood test result is between 3 and 20 ng/mL.
- You had a prostate MRI at the study hospital with complete images.
- You either had a biopsy that found no significant cancer, or you have not had a biopsy and your MRI shows low-risk findings.
- You do not have a pacemaker, severe claustrophobia, or metal implants that would interfere with MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
This study explores using repeated MRI scans to catch prostate cancer early in men who have never had a biopsy. If you have a suspicious spot on an MRI, you might be able to get careful monitoring without immediate biopsy, which could help avoid unnecessary procedures.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
This study tests if a special MRI measurement (ADC) can improve how well a standard MRI finds prostate cancer. If you have a suspicious MRI and are scheduled for a biopsy, this might help better understand your results.
This trial is testing a new, faster type of MRI scan (called biparametric MRI) to see if it can detect prostate cancer as well as the standard scan. It may help you avoid a longer scan and possibly reduce the need for contrast dye.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.